- Home
- AREC vs RNAC Comparison
AREC vs RNAC Comparison
Compare AREC & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AREC | RNAC |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.5M | 238.9M |
| IPO Year | 2013 | 2016 |
Fundamental Metrics
Financial Performance| Metric | AREC | RNAC |
|---|---|---|
| Price | $2.47 | $9.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $6.50 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 1.9M | 101.9K |
| Earning Date | 06-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 223.53 | N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $38,462.50 | N/A |
| P/E Ratio | $3.89 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.48 | $5.60 |
| 52 Week High | $7.11 | $11.00 |
Technical Indicators
Market Signals| Indicator | AREC | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 48.36 |
| Support Level | $2.41 | $8.80 |
| Resistance Level | $2.53 | $9.27 |
| Average True Range (ATR) | 0.15 | 0.69 |
| MACD | -0.05 | -0.12 |
| Stochastic Oscillator | 36.79 | 17.14 |
Price Performance
Historical ComparisonAbout AREC American Resources Corporation
American Resources Corp is engaged in the aggregation, recovery, recycling, and sale of recovered metal and steel materials. The company operates through two segments: Corporate and Electrified Materials. The Electrified Materials segment focuses on processing and recycling recovered metal and steel products.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.